Damoctocog alpha pegol
Infobox drug articles without a structure image

Drug has EMA link

Damoctocog alfa pegol, nke ana-ere n'okpuru aha Jivi bụ ọgwụ  ngwako ọnụ nke eji agwọ hemofilia

Mmetụta ndị ana-ahụkarị na-agụnye isi ọwụwa, ụkwara, agbọ onunu na ahụ ọkụ.

A kwadoro Damoctocog alfa pegol (ihe na-emegide ọbara mgbali elu- recombinant pegylated-aucl) maka iji ọgwụ na United States n'ọnwa Ọgọstụ 2018, na European Union na Nọvemba 2018.

Etu esi anụ ọgwụ 
Na United States, a na-egosi damoctocog alfa pegol maka iji ya mee ihe na ndị okenye na ndị nọ n'afọ iri na ụma (afọ iri na abụọ ma ọ bụ karịa) nwere hemophilia A (nchaghị nke Factor VIII) maka: (1) Ọgwụgwọ na njikwa nke ọbara ọgbụgba; (2) Nchịkwa oge nke ọbara ọwụwa; (3) Mgbochi usoro iji belata ugboro ole ọbara ọgbụrụ.

Na ngalaba irope, ana egosi na ọgwụ damoctocog alfa pegol bu na maka ọgwụgwọ na mgbochi nke ọbara ọgbụgba na ndị a gwọrọ n'oge gara aga na haemophilia A (ihe ọmụmụ nke asatọ).

Edensibia

Njikọ ndị ọzọ 

 
 Clinical trial number NCT01184820 for "Trial to Evaluate the Pharmacokinetics and Safety Profile of BAY94-9027 Following Single and Multiple Dose Administration" at ClinicalTrials.gov
 Clinical trial number NCT01580293 for "A Trial Investigating Safety and Efficacy of Treatment With BAY94-9027 in Severe Hemophilia A (PROTECT-VIII)" at ClinicalTrials.gov
 Clinical trial number NCT01775618 for "Safety and Efficacy of BAY94-9027 in Previously Treated Male Children With Haemophilia A" at ClinicalTrials.gov